Are you currently in the process of designing, setting up or planning your research study, and would like to extend your project into the NHS?
Yes? Then you may want to take advantage of this training opportunity.
Oliver Hopper (Research & Development Coordinator, Royal Bournemouth and Christchurch Hospital) and Suzy Wignall (Clinical Governance Advisor, R&KEO) will be running a training session on how to use, and complete your own application within the IRAS system.
IRAS (Integrated Research Application System) is the system used to gain approvals from the NHS Research Ethics Committee and Health Research Authority, before rolling out your study to NHS Trusts. To support this, the session will include the background to research ethics and the approvals required for NHS research.
The session will also be interactive, and so as participants, you will have the opportunity to go through the form itself and complete the sections, with guidance on what the reviewers are expecting to see in your answers, and tips on how to best use the system.
The training will take place in Studland House, room 103 on Thursday 23rd August, at 13:00pm – 16:00pm.
Get in touch with researchethics@bournemouth.ac.uk if you would like to register your interest and book a place.
Training opportunity – completing and submitting your IRAS application










3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
Prof Marahatta promoting BU-Nepal collaboration
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease